You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
國家醫保局、中醫藥管局:將符合條件中藥飲片、中成藥等納入醫保藥品目錄
國家醫療保障局、國家中醫藥管理局印發《關於醫保支持中醫藥傳承創新發展的指導意見》,意見提出,規定將符合條件的中藥飲片、中成藥、醫療機構中藥製劑等納入醫保藥品目錄。將經國家談判納入醫保目錄的中成藥配備、使用納入監測評估。充分利用「雙通道」藥品管理機制,將參保患者用藥的渠道拓展到定點零售藥店,更好地保障參保羣衆用藥需求。 各地應根據基金承受能力和臨牀需要,按程序將符合條件的民族藥、醫療機構中藥製劑和中藥飲片納入本地醫保支付範圍,並建立動態調整機制。將符合《處方管理辦法》和《醫院中藥飲片管理規範》但超出《中華人民共和國藥典》規定常用劑量開具的中藥飲片納入醫保支付範圍。 同仁堂國藥(03613.HK)全日股價彈11.7%,中國中藥(00570.HK)揚12.4%,而白雲山(00874.HK)股價升6.4%。
Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account